10 patienter ud af 1 000 undgå en ny iskæmisk hændelse inden for 2 år efter at have valgt Plavix i stedet for aspirin).
Risk reduction means that fewer patients will have new ischaemic events when they receive Plavix, than if they receive aspirin (in other words, about 10 patients in 1,000 will avoid having a new ischaemic event within two years of starting Plavix instead of aspirin).